Table of Contents

1 Study Coverage

• 1.1 Antibiotics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Antibiotics Market Size Growth Rate by Product
  • 1.4.2 Cephalosporins
  • 1.4.3 Penicillins
  • 1.4.4 Fluoroquinolones
  • 1.4.5 Macrolides
  • 1.4.6 Carbapenems
  • 1.4.7 Aminoglycosides
  • 1.4.8 Sulfonamides
  • 1.4.9 Other
• 1.5 Market by End User
  • 1.5.1 Global Antibiotics Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Antibiotics Market Size
  • 2.1.1 Global Antibiotics Revenue 2014-2025
  • 2.1.2 Global Antibiotics Sales 2014-2025
• 2.2 Antibiotics Growth Rate by Regions
  • 2.2.1 Global Antibiotics Sales by Regions
  • 2.2.2 Global Antibiotics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Antibiotics Sales by Manufacturers
  • 3.1.1 Antibiotics Sales by Manufacturers
  • 3.1.2 Antibiotics Sales Market Share by Manufacturers
  • 3.1.3 Global Antibiotics Market Concentration Ratio (CR5 and HHI)
• 3.2 Antibiotics Revenue by Manufacturers
  • 3.2.1 Antibiotics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antibiotics Revenue Share by Manufacturers (2014-2019)
• 3.3 Antibiotics Price by Manufacturers
• 3.4 Antibiotics Manufacturing Base Distribution, Product Types
  • 3.4.1 Antibiotics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Antibiotics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Antibiotics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Antibiotics Sales by Product
• 4.2 Global Antibiotics Revenue by Product
• 4.3 Antibiotics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Antibiotics Breakdown Data by End User

6 North America

• 6.1 North America Antibiotics by Countries
  • 6.1.1 North America Antibiotics Sales by Countries
  • 6.1.2 North America Antibiotics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Antibiotics by Product
• 6.3 North America Antibiotics by End User

7 Europe

• 7.1 Europe Antibiotics by Countries
  • 7.1.1 Europe Antibiotics Sales by Countries
  • 7.1.2 Europe Antibiotics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Antibiotics by Product
• 7.3 Europe Antibiotics by End User

8 Asia Pacific

• 8.1 Asia Pacific Antibiotics by Countries
  • 8.1.1 Asia Pacific Antibiotics Sales by Countries
  • 8.1.2 Asia Pacific Antibiotics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Antibiotics by Product
• 8.3 Asia Pacific Antibiotics by End User

9 Central & South America

• 9.1 Central & South America Antibiotics by Countries
  • 9.1.1 Central & South America Antibiotics Sales by Countries
  • 9.1.2 Central & South America Antibiotics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Antibiotics by Product
• 9.3 Central & South America Antibiotics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Antibiotics by Countries
  • 10.1.1 Middle East and Africa Antibiotics Sales by Countries
  • 10.1.2 Middle East and Africa Antibiotics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Antibiotics by Product
• 10.3 Middle East and Africa Antibiotics by End User

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Antibiotics Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Janssen Pharmaceuticals
  • 11.2.1 Janssen Pharmaceuticals Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Janssen Pharmaceuticals Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Janssen Pharmaceuticals Antibiotics Products Offered
  • 11.2.5 Janssen Pharmaceuticals Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Abbott Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Abbott Antibiotics Products Offered
  • 11.3.5 Abbott Recent Development
• 11.4 GlaxoSmithKline
  • 11.4.1 GlaxoSmithKline Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 GlaxoSmithKline Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 GlaxoSmithKline Antibiotics Products Offered
  • 11.4.5 GlaxoSmithKline Recent Development
• 11.5 Sanofi
  • 11.5.1 Sanofi Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Sanofi Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Sanofi Antibiotics Products Offered
  • 11.5.5 Sanofi Recent Development
• 11.6 Novartis
  • 11.6.1 Novartis Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Novartis Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Novartis Antibiotics Products Offered
  • 11.6.5 Novartis Recent Development
• 11.7 Bayer
  • 11.7.1 Bayer Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Bayer Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Bayer Antibiotics Products Offered
  • 11.7.5 Bayer Recent Development
• 11.8 Bristol Myers Squibb Company
  • 11.8.1 Bristol Myers Squibb Company Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bristol Myers Squibb Company Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bristol Myers Squibb Company Antibiotics Products Offered
  • 11.8.5 Bristol Myers Squibb Company Recent Development
• 11.9 Eli Lilly and Company
  • 11.9.1 Eli Lilly and Company Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Eli Lilly and Company Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Eli Lilly and Company Antibiotics Products Offered
  • 11.9.5 Eli Lilly and Company Recent Development
• 11.10 Astellas Pharma
  • 11.10.1 Astellas Pharma Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Astellas Pharma Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Astellas Pharma Antibiotics Products Offered
  • 11.10.5 Astellas Pharma Recent Development

12 Future Forecast

• 12.1 Antibiotics Market Forecast by Regions
  • 12.1.1 Global Antibiotics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Antibiotics Revenue Forecast by Regions 2019-2025
• 12.2 Antibiotics Market Forecast by Product
  • 12.2.1 Global Antibiotics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Antibiotics Revenue Forecast by Product 2019-2025
• 12.3 Antibiotics Market Forecast by End User
• 12.4 North America Antibiotics Forecast
• 12.5 Europe Antibiotics Forecast
• 12.6 Asia Pacific Antibiotics Forecast
• 12.7 Central & South America Antibiotics Forecast
• 12.8 Middle East and Africa Antibiotics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Antibiotics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
More than 15.0% of the deaths, in children below the age of five, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the highest prevalence of the disease is identified to be in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.
The global Antibiotics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibiotics market based on company, product type, end user and key regions.

This report studies the global market size of Antibiotics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibiotics in these regions.
This research report categorizes the global Antibiotics market by top players/brands, region, type and end user. This report also studies the global Antibiotics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Janssen Pharmaceuticals
Abbott
GlaxoSmithKline
Sanofi
Novartis
Bayer
Bristol Myers Squibb Company
Eli Lilly and Company
Astellas Pharma

Market size by Product
Cephalosporins
Penicillins
Fluoroquinolones
Macrolides
Carbapenems
Aminoglycosides
Sulfonamides
Other
Market size by End User
Hospital
Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Antibiotics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antibiotics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antibiotics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antibiotics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antibiotics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibiotics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.